Main navigation

About Us
Commitments
- Innovation Hub
Products
Partnerships
- Grants
- Partnerships for the Future
News
- In The News
- Archive
Events
Investors
Careers

Home
Investors
In the News
Archive
Events

Pacira in the News

Recent News

Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology

04/14/21

Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021

04/07/21

Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients

03/22/21

Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021

03/09/21

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

03/03/21

Browse the press release archive

Shareholder Tools

Print Page
RSS Feeds
Email Alerts

Contact Us
Legal
Site Map
Privacy Notice

EXPAREL^® (bupivacaine liposome injectable suspension), the EXPAREL logo, iovera^o, the iovera^o logo, Pacira, and the Pacira logo are registered trademarks of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.